Treatment of Intractable Pruritus in Drug Induced Cholestasis with Albumin Dialysis: A Report of Two Cases

Cholestatic liver injury can be caused by a variety of drugs and is difficult to treat. We report two patients, a 22 year old male and a 55 year old female, with drug induced cholestasis caused by anabolic-androgenic steroids (silabolin and nandrolone) and by fluoxetine, respectively. Both patients presented with massive jaundice and severe pruritus resulting in sleep deprivation and suicide ideation. Laboratory examination revealed signs of cholestasis. Medical treatment was ineffective; therefore, extra-corporeal albumin dialysis using the molecular adsorbent recirculating system (MARS) was started. Three treatments with a mean duration of 16 hours were performed in each patient. The procedure was well tolerated by the patients and resulted in a sustained relief of pruritus as well as in a decline of plasma bilirubin and serum 3&agr;-hydroxy bile acid levels. The mean plasma bilirubin concentration decreased from 25.27 mg/dl to 10.7 mg/dl; the mean serum 3&agr;-hydroxy bile acid concentration decreased from 299 μmol/L to 88 μmol/L. After 2 months, the pruritus had nearly vanished in both patients, and there was a further decline of bilirubin levels after discharge from hospital. In conclusion, extracorporeal albumin dialysis appears to be a therapeutic option in severe drug induced cholestasis refractory to medical treatment.

[1]  H. Schwaighofer,et al.  Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  I. Marino,et al.  Effect of molecular adsorbent recirculating system in hepatitis C virus‐related intractable pruritus , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  U. Beuers,et al.  Extrahepatic manifestations of cholestasis , 2002, Journal of gastroenterology and hepatology.

[4]  E. Ben-Chetrit,et al.  Paroxetine Associated Hepatotoxicity: A Report of 3 Cases and a Review of the Literature , 2002, Pharmacopsychiatry.

[5]  A. Hofmann Cholestatic liver disease: pathophysiology and therapeutic options. , 2002, Liver.

[6]  C. Franssen,et al.  Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). , 2002, Liver.

[7]  P. Berloco,et al.  Use of MARS in the Treatment of Acute Liver Failure: Preliminary Monocentric Experience , 2001 .

[8]  R. Cortesini,et al.  Use of MARS in the treatment of acute liver failure: preliminar monocentric experience. , 2001, Transplantation proceedings.

[9]  C. Sempoux,et al.  Drug and toxin‐induced bile duct disorders , 2000, Journal of gastroenterology and hepatology.

[10]  M. Löhr,et al.  Liver support by extracorporeal blood purification: A clinical observation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  C. Ghent The pruritus of cholestasis , 1999, Hepatology.

[12]  M. Löhr,et al.  Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. , 1999, Artificial organs.

[13]  G. Gores,et al.  Cholestasis confers resistance to the rat liver mitochondrial permeability transition. , 1998, Gastroenterology.

[14]  E. Gabazza,et al.  Polyethylene glycol-modified bilirubin oxidase improves hepatic energy charge and urinary prostaglandin levels in rats with obstructive jaundice. , 1998, Journal of hepatology.

[15]  N. Bergasa,et al.  Why do cholestatic patients itch? , 1996, Gut.

[16]  R. Melchert,et al.  Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. , 1995, Journal of pharmacological and toxicological methods.

[17]  D. Alling,et al.  Effects of Naloxone Infusions in Patients with the Pruritus of Cholestasis: A Double-Blind, Randomized, Controlled Trial , 1995, Annals of Internal Medicine.

[18]  J. Ostrow,et al.  Pruritus in hepatic cholestasis. Pathogenesis and therapy. , 1985, Archives of dermatology.

[19]  Roger Williams,et al.  Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. , 2003, Journal of hepatology.

[20]  J. George,et al.  Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs , 2002, Seminars in liver disease.

[21]  J. Boyer,et al.  Mechanisms of Hepatic Transport of Drugs: Implications for Cholestatic Drug Reactions , 2002, Seminars in liver disease.

[22]  G. Gores,et al.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.

[23]  N. Kawada,et al.  [Drug-induced cholestasis]. , 1995, Ryoikibetsu shokogun shirizu.